Miguel Chillón

Miguel Chillón

Miguel Chillón
Cargo

Head of the Laboratory of Gene Therapy in Neurodegenerative Diseases of the VHIR-UAB Mixed Unit

Reactions: New particles designed from bacteria-infecting viruses to improve gene therapy

A team of scientists led by the Catholic University of America in Washington has designed new artificial vectors based on viruses to improve gene therapy processes. The main novelty is that they are constructed from viruses that infect bacteria. Among other advantages, this would make it possible to avoid the possible memory of our defences against them and have a greater capacity. According to the authors, who publish their results in the journal Nature Communications, these nanoparticles "have the potential to transform gene therapies and personalised medicine".

0